Page 19 - ANUARIO

uploads/2020/03/COVID-IHU-2-1.pdf
9 - Gupta N, Agrawal S, Ish P .Chloroquine in COVID-19: the evidence. Monaldi Arch Chest Dis.
2020; 90(1). doi: 10.4081/monaldi.2020.1290.
10 - Arshad S, Kilgore P, Chaudhry ZS, et al. Treatment with hydroxychloroquine, azithromycin, and
combination in patients hospitalized with COVID-19. Int J Infect Dis. 2020; 97: 396-403.
11 - Yu B, Li C, Chen P, et al. Low dose of hydroxychloroquine reduces fatality of critically ill patients
with COVID-19. Sci China Life Sci. 2020; 63(10): 1515-1521.
12 - Mahévas M, Tran V, Roumier M, et al. Clinical efficacy of hydroxychloroquine in patients with
covid-19 pneumonia who require oxygen: observational comparative study using routine care data.BMJ
2020;369:m1844.
13 - Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Pa-
tients with Covid-19. N Engl J Med 2020; 382(25): 2411-2418.
14 - Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate co-
ronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020; 369: m1849
15 - Cavalcanti A, Zampieri F, Rosa RG, et al. Hydroxychloroquine with or without Azithromycin in
Mild-to-Moderate Covid-19. N Engl J Med. 2020. PMID: 32706953.
16 - Pan H, Peto R, Karim QA, et al. Repurposed antiviral drugs for COVID-19–interim WHO SOLIDA-
RITY trial results. (medRxiv preprint doi: https://doi.org/10.1101/2020.10.15.20209817. Version posted
October 15, 2020)
17 - RECOVERY Collaborative Group. Effect of Hydroxychloroquine in Hospitalized Patients with
COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. (medRxiv preprint doi:
https://doi.org/10.1101/2020.07.15.20151852. Version posted July 15, 2020).

19